Search

Your search keyword '"Scaravaglio, M"' showing total 8 results
Start Over Author "Scaravaglio, M" Journal digestive and liver disease
8 results on '"Scaravaglio, M"'

1. OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEALVARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED ADVANCED CHRONIC LIVER DISEASE

Author

Calvaruso, V., primary, Celsa, C., additional, Cristoferi, L., additional, Scaravaglio, M., additional, Capodicasa, L., additional, Di Maria, G., additional, Cadamuro, L., additional, Gerussi, A., additional, Malinverno, F., additional, Lampertico, P., additional, Cazzagon, N., additional, Marzioni, M., additional, Vespasiani Gentilucci, U., additional, Andreone, P., additional, Lleo, A., additional, Rigamonti, C., additional, Viganò, M., additional, Giannini, E.G., additional, Russello, M., additional, Vanni, E., additional, Cerini, F., additional, Missale, G., additional, Brunetto, M.R., additional, Niro, G., additional, Vettori, G., additional, Castellaneta, A., additional, Cardinale, V., additional, Alvaro, D., additional, Mega, A., additional, Pace Palitti, V., additional, Bellanti, F., additional, Di Marco, V., additional, Invernizzi, P., additional, Cammà, C., additional, and Carbone, M., additional

Published
2024
Full Text
View/download PDF

2. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

Author

Terracciani, F., primary, De Vincentis, A., additional, D'Amato, D., additional, Invernizzi, P., additional, Morgando, A., additional, Vanni, E., additional, Viganò, M., additional, Alvaro, D., additional, Venere, R., additional, Lleo, A., additional, Colapietro, F., additional, Degasperi, E., additional, Viganò, R., additional, Giannini, E.G., additional, Labanca, S., additional, Feletti, V., additional, Mussetto, A., additional, Cozzolongo, R., additional, Losito, F., additional, Pompili, M., additional, Ponziani, F.R., additional, Niro, G.A., additional, Cotugno, R., additional, Pozzoni, P., additional, Chessa, L., additional, Cuccorese, G., additional, Palitti, V. Pace, additional, Russello, M., additional, Cannavò, M., additional, Frazzetto, E., additional, Bertino, G., additional, Marzioni, M., additional, Terreni, N., additional, Zolfino, T., additional, Saitta, C., additional, Pellicelli, A., additional, Coco, B., additional, Brunetto, M., additional, Cazzagon, N., additional, Floreani, A., additional, Muratori, L., additional, Rosina, F., additional, Di Stefano, M., additional, Scifo, G., additional, Baiocchi, L., additional, Grassi, G., additional, Sacco, R., additional, Izzi, A., additional, Crocè, S. Lory, additional, Fiorini, C., additional, Marra, F., additional, Simone, L., additional, Morelli, O., additional, Abenavoli, L., additional, Pizzolante, F., additional, De Matthaeis, N., additional, Scaravaglio, M., additional, Gimignani, G., additional, Boano, V., additional, Manfredi, G.F., additional, Marignani, M., additional, Fanella, S., additional, Giacchetto, M., additional, Castellaneta, A., additional, Poggi, G., additional, Buzzanca, V., additional, Scivetti, P., additional, Tortora, A., additional, Casella, S., additional, Bellia, V., additional, Omazzi, B.F., additional, Alagna, G., additional, Ricci, C., additional, Poisa, P., additional, Rigamonti, C., additional, Calvaruso, V., additional, Carbone, M., additional, and Vespasiani-Gentilucci, U., additional

Published
2023
Full Text
View/download PDF

3. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

Author

De Vincentis, A., primary, Terracciani, F., additional, D'Amato, D., additional, Invernizzi, P., additional, Morgando, A., additional, Vanni, E., additional, Viganò, M., additional, Alvaro, D., additional, Venere, R., additional, Lleo, A., additional, Colapietro, F., additional, Degasperi, E., additional, Viganò, R., additional, Giannini, E.G., additional, Labanca, S., additional, Feletti, V., additional, Mussetto, A., additional, Cozzolongo, R., additional, Losito, F., additional, Pompili, M., additional, Ponziani, F.R., additional, Niro, G.A., additional, Cotugno, R., additional, Pozzoni, P., additional, Chessa, L., additional, Cuccorese, G., additional, Palitti, V. Pace, additional, Russello, M., additional, Cannavò, M., additional, Frazzetto, E., additional, Bertino, G., additional, Marzioni, M., additional, Terreni, N., additional, Zolfino, T., additional, Saitta, C., additional, Pellicelli, A., additional, Coco, B., additional, Brunetto, M., additional, Cazzagon, N., additional, Floreani, A., additional, Muratori, L., additional, Rosina, F., additional, Di Stefano, M., additional, Scifo, G., additional, Baiocchi, L., additional, Grassi, G., additional, Sacco, R., additional, Izzi, A., additional, Crocè, Saveria Lory, additional, Fiorini, Cecilia, additional, Marra, Fabio, additional, Simone, Loredana, additional, Morelli, Olivia, additional, Abenavoli, L., additional, Pizzolante, F., additional, De Matthaeis, N., additional, Scaravaglio, M., additional, Gimignani, G., additional, Boano, V., additional, Manfredi, G.F., additional, Marignani, M., additional, Fanella, S., additional, Giacchetto, M., additional, Castellaneta, A., additional, Poggi, G., additional, Buzzanca, V., additional, Scivetti, P., additional, Tortora, A., additional, Casella, S., additional, Bellia, V., additional, Omazzi, B.F., additional, Alagna, G., additional, Ricci, C., additional, Poisa, P., additional, Rigamonti, C., additional, Calvaruso, V., additional, Vespasiani-Gentilucci, U., additional, and Carbone, M., additional

Published
2023
Full Text
View/download PDF

4. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

Author

Cristoferi, L., primary, Porta, M., additional, Bernasconi, D.P., additional, Leonardi, F., additional, Gerussi, A., additional, Mulinacci, G., additional, Palermo, A., additional, Gallo, C., additional, Scaravaglio, M., additional, Stucchi, E., additional, Maino, C., additional, Ippolito, D., additional, D'Amato, D., additional, Ferreira, C., additional, Nardi, A., additional, Banerjee, R., additional, Valsecchi, M.G., additional, Antolini, L., additional, Corso, R., additional, Sironi, S., additional, Fagiuoli, S., additional, Invernizzi, P., additional, and Carbone, M., additional

Published
2022
Full Text
View/download PDF

5. T.08.1 CHARACTERISTICS AND PREDICTORS OF LIVER TOXICITY IN ADVANCED BREAST CANCER PATIENTS TREATED WITH CYCLINDEPENDENT KINASE INHIBITORS: AN OBSERVATIONAL STUDY

Author

Ciaccio, A., primary, Scaravaglio, M., additional, Laffusa, A., additional, Lucà, M., additional, Longo, S., additional, Manna, M., additional, Maggioni, C., additional, Riva, F., additional, Cicchiello, F., additional, Cazzaniga, M.E., additional, Cortinovis, D.L., additional, and Invernizzi, P., additional

Published
2022
Full Text
View/download PDF

6. PC.01.8 RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

Author

Cristoferi, L., primary, Porta, M., additional, Bernasconi, D.P., additional, Leonardi, F., additional, Mulinacci, G., additional, Palermo, A., additional, Gerussi, A., additional, Scaravaglio, M., additional, Gallo, C., additional, D’Amato, D., additional, Maino, C., additional, Ippolito, D., additional, Ferreira, C., additional, Mavar, M., additional, Rajarshi, B., additional, Antolini, L., additional, Valsecchi, M.G., additional, Fagiuoli, S., additional, Invernizzi, P., additional, and Carbone, M., additional

Published
2022
Full Text
View/download PDF

7. Radiomics-based model for outcome prediction in primary sclerosing cholangitis

Author

Cristoferi, L., primary, Porta, M., additional, Bernasconi, D.P., additional, Leonardi, F., additional, Mulinacci, G., additional, Palermo, A., additional, Gerussi, A., additional, Gallo, C., additional, Scaravaglio, M., additional, Stucchi, E., additional, Maino, C., additional, Ippolito, D., additional, D'Amato, D., additional, Ferreira, C., additional, Mavar, M., additional, Banerjee, R., additional, Antolini, L., additional, Valsecchi, M.G., additional, Fagiuoli, S., additional, Invernizzi, P., additional, and Carbone, M., additional

Published
2022
Full Text
View/download PDF

8. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

Author

Laura Cristoferi, Marco Porta, Davide Paolo Bernasconi, Filippo Leonardi, Alessio Gerussi, Giacomo Mulinacci, Andrea Palermo, Camilla Gallo, Miki Scaravaglio, Eliana Stucchi, Cesare Maino, Davide Ippolito, Daphne D'Amato, Carlos Ferreira, Alessandra Nardi, Rajarshi Banerjee, Maria Grazia Valsecchi, Laura Antolini, Rocco Corso, Sandro Sironi, Stefano Fagiuoli, Pietro Invernizzi, Marco Carbone, Cristoferi, L, Porta, M, Bernasconi, D, Leonardi, F, Gerussi, A, Mulinacci, G, Palermo, A, Gallo, C, Scaravaglio, M, Stucchi, E, Maino, C, Ippolito, D, D'Amato, D, Ferreira, C, Nardi, A, Banerjee, R, Valsecchi, M, Antolini, L, Corso, R, Sironi, S, Fagiuoli, S, Invernizzi, P, and Carbone, M

Subjects
sclerosing cholangitis, Artificial intelligence, Hepatology, Prognostic score, Gastroenterology, Primary sclerosing cholangiti, MRCP
Abstract

Background: Magnetic resonance cholangiopancreatography (MRCP) is the gold standard for diagnosis of patients with primary sclerosing cholangitis (PSC). The semi-quantitative MRCP-derived Anali scores proposed for risk stratification, have poor-to-moderate inter-reader agreement. Aims: To evaluate the prognostic performance of quantitative MRCP metrics in PSC. Methods: This is a retrospective study of PSC patients undergoing MRCP. Images were processed using MRCP+ software (Perspectum Ltd, Oxford) that provides quantitative biliary features, semi-automatically extracted by artificial intelligence-driven analysis of MRCP-3D images. The prognostic value of biliary features has been assessed for all hepato-biliary complications. Results: 87 PSC patients have been included in the analysis. Median follow-up from MRCP to event/censoring of 30.9 months (Q1-Q3=13.6–46.6). An adverse outcome occurred in 27 (31.0%) patients. The number of biliary strictures (HR=1.05 per unit, 95%CI 1.02–1.08, p < 0.0001), spleen length (HR=1.16 per cm, 95%CI 1.01–1.34, p = 0.039), adjusted for height, age at MRCP, and time from diagnosis to MRCP predicted higher risk of hepatobiliary complications. These were incorporated into a the quantitative MRCP-derived PSC (qMRCP-PSC) score (C-statistic=0.80). After 3-fold cross-validation, qMRCP-PSC outperformed the Anali score in our cohort (C-statistic of 0.78 vs 0.64) and enabled the discrimination of survival of PSC patients (log-rank p < 0.0001). Conclusions: The qMRCP-PSC score identified patients at higher risk of hepatobiliary complications and outperformed the available radiological scores. It represents a novel quantitative biomarker for disease monitoring and a potential surrogate endpoint for clinical trials.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results